These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 16119035)

  • 61. Growth problems in children with asthma.
    Wolthers OD
    Horm Res; 2002; 57 Suppl 2():83-7. PubMed ID: 12065934
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Do inhaled corticosteroids impair long-term growth in prepubertal cystic fibrosis patients?
    De Boeck K; De Baets F; Malfroot A; Desager K; Mouchet F; Proesmans M
    Eur J Pediatr; 2007 Jan; 166(1):23-8. PubMed ID: 16799799
    [TBL] [Abstract][Full Text] [Related]  

  • 63. One year follow-up study of endocrine and lung function of asthmatic children on inhaled budesonide.
    Nikolaizik WH; Preece MA; Warner JO
    Eur Respir J; 1997 Nov; 10(11):2596-601. PubMed ID: 9426102
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effects of inhaled corticosteroids on growth.
    MacKenzie C
    J Allergy Clin Immunol; 1998 Apr; 101(4 Pt 2):S451-5. PubMed ID: 9563371
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Influence of inhaled corticosteroids on pubertal growth and final height in asthmatic children.
    De Leonibus C; Attanasi M; Roze Z; Martin B; Marcovecchio ML; Di Pillo S; Chiarelli F; Mohn A
    Pediatr Allergy Immunol; 2016 Aug; 27(5):499-506. PubMed ID: 26919136
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Symptomatic adrenal insufficiency during inhaled corticosteroid treatment.
    Patel L; Wales JK; Kibirige MS; Massarano AA; Couriel JM; Clayton PE
    Arch Dis Child; 2001 Oct; 85(4):330-4. PubMed ID: 11567945
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Gender and age risks for hoarseness and dysphonia with use of a dry powder fluticasone propionate inhaler in asthma.
    Ishizuka T; Hisada T; Aoki H; Yanagitani N; Kaira K; Utsugi M; Shimizu Y; Sunaga N; Dobashi K; Mori M
    Allergy Asthma Proc; 2007; 28(5):550-6. PubMed ID: 18034974
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cost analysis of the use of inhaled corticosteroids in the treatment of asthma: a 1-year follow-up.
    Stempel DA; McLaughlin T; Griffis DL; Stanford RH
    Respir Med; 2001 Dec; 95(12):992-8. PubMed ID: 11778798
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Systemic availability of inhaled budesonide and fluticasone propionate: healthy versus asthmatic lungs.
    Harrison TW
    BioDrugs; 2001; 15(6):405-11. PubMed ID: 11520251
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Dose-response studies of fluticasone propionate and budesonide: classification based on asthma severity.
    Mikhak Z
    Allergy Asthma Proc; 2006; 27(5):402-11. PubMed ID: 17063671
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Inhaled corticosteroids used for the control of asthma in a "real-life" setting do not affect linear growth velocity in prepubertal children.
    Erceg D; Nenadic N; Plavec D; Nogalo B; Turkalj M
    Med Sci Monit; 2012 Sep; 18(9):CR564-8. PubMed ID: 22936192
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The effect of intranasal and inhaled corticosteroids in healthy volunteers on the number of circulating lymphocytes and lymphocyte subsets.
    Fokkens WJ; van de Merwe JP; Braat JP; Overbeek SE; Hooijkaas H
    Allergy; 1999 Feb; 54(2):158-64. PubMed ID: 10221439
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effect of delivery device on systemic exposure to inhaled fluticasone propionate in children with asthma.
    Nilsson E; Chawes BL; Bønnelykke K; Vindfeld S; Moore AC; Bisgaard H
    Br J Clin Pharmacol; 2014 Aug; 78(2):435-7. PubMed ID: 24527946
    [No Abstract]   [Full Text] [Related]  

  • 74. Side-effects of high-dose fluticasone propionate in children.
    Todd GR
    Eur Respir J; 1999 Mar; 13(3):707-9. PubMed ID: 10232453
    [No Abstract]   [Full Text] [Related]  

  • 75. Effects of fluticasone propionate on bone mineral density in patients with persistent bronchial asthma.
    Ishizuka T; Yoshii A; Hisada T; Tsukagoshi H; Okayama Y; Iizuka K; Dobashi K; Nakazawa T; Mori M
    Intern Med; 2002 Oct; 41(10):798-804. PubMed ID: 12412999
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Acute adrenal crisis in asthmatics treated with high-dose fluticasone propionate.
    Todd GR; Acerini CL; Buck JJ; Murphy NP; Ross-Russell R; Warner JT; McCance DR
    Eur Respir J; 2002 Jun; 19(6):1207-9. PubMed ID: 12108877
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Impact of inhaled and intranasal corticosteroids on the growth of children.
    Wolthers OD
    BioDrugs; 2000 May; 13(5):347-57. PubMed ID: 18034541
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The risk of cataract among users of inhaled steroids.
    Jick SS; Vasilakis-Scaramozza C; Maier WC
    Epidemiology; 2001 Mar; 12(2):229-34. PubMed ID: 11246585
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Comparing Budesonide and Fluticasone Propionate in Children with Moderate to Severe Asthma: A Pilot Randomized Controlled Trial.
    Sadeghzadeh M; Khoshnevisasl P; Ahmadiafshar A; Motamed N; Pourmarjani A
    Iran J Allergy Asthma Immunol; 2023 Dec; 22(6):527-535. PubMed ID: 38477950
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Inhaled corticosteroids and bone density of children with asthma.
    Bahceciler NN; Sezgin G; Nursoy MA; Barlan IB; Basaran MM
    J Asthma; 2002 Apr; 39(2):151-7. PubMed ID: 11990230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.